EIB lends €100 million to Finnish company Orion Pharma for new cancer and pain treatments
The European Investment Bank (EIB) is lending €100 million to Finnish pharmaceutical company Orion Pharma to develop new treatments for cancer, pain and other serious conditions with few treatment options.
The financing will support Orion Pharma’s research and development activities across its European centres, covering personnel costs, clinical trials, patenting and investments in specialised laboratory equipment. By reinforcing Orion Pharma’s long-term R&D capacity, the EIB is helping strengthen Europe’s competitiveness in advanced biopharmaceutical innovation.
Read full announcement (external link)
Originally published on 15 Apr
Announcements are published as a service to readers. The sender is responsible for all content. Announcements for publication can be submitted to announcements@thehanseatic.com.
Estonia opened the first Business Hub in U.S. Located at the Embassy of Estonia in Washington, D.C., the Business Hub will serve as a bridge between Estonian companies and the vast business opportunities in the U.S. market. A delegation of Estonian defence industry innovators was present at the opening event, also attending the annual AUSA conference.
Read full announcement (external link)
Originally published on 17 Oct